Asia Pacific Drug Delivery Devices Market Research Report – Segmented By Route of Administration, By Facility of Use, By Country (India, China, Japan, Australia, South Korea and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2024 to 2029)

Updated On: June, 2024
ID: 2254
Pages: 180

APAC Drug Delivery Devices Market Size (2024 to 2029)

The Drug Delivery Devices Market size in the Asia Pacific region was valued at USD 245.88 Million in 2024 and is expected to be USD 346.47 Million by 2029, growing at a CAGR of 7.1% during the forecast period.

There are many growth contributing factors responsible for market growth in terms of the drug delivery devices market. Drug delivery devices are medical equipment used for introducing a drug into human bodies and various systems in human bodies. Various routes of administration techniques do the administration of a drug into human bodies. Factors such as an increase in the prevalence of chronic diseases, the spread of infections, increased population where the pediatric and geriatric ratio contributes to the market's growth. Other factors, such as the increased adaption of therapeutic medicines and surgeries, increased awareness of early detection of diseases, and treatment, also increase the market growth. These devices are most often therapeutically used. Developed research activities across the country, technological advancements are observed in the forecast period and are major market drivers. Government initiatives towards creating awareness in public about early detection of diseases and its treatment, fundraisings from NGOs, and the public drive growth for this market.  

For handling and associating with these devices and equipment, a lot of caring and staff are required. Skilled persons, professionals are always needed to carry out these processes. Increased complications associated with delivering and manufacturing medicines hamper the market growth. Administrating selected drugs to targeted sites is hard to achieve. There are also a lot of safety concerns with this market. There are stringent regulations, and the approval committee for providing grants for these devices makes this market more challenging to achieve its goals.

This research report on the Asia-Pacific Drug Delivery Devices Market has been segmented and sub-segmented into the following categories:

  • By Route of Administration: Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Tran mucosal Drug Delivery.
  • By End-User: Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers.
  • By Region: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis: 

The Asia Pacific expects the highest market growth during the forecast period. China and Japan regions are noted as highly populated across Asia pacific. Hence the rise in populations leads to demand for the availability of drugs and drug-delivering devices. In regions like India, the government has brought up many initiatives to support health care and patient safety. It raises awareness in the public about the early detection of diseases and their treatment. Hence the drug administration process is monetarily done. Increased technological developments, research activities, rise in investors, and public funders for this market, increased demand for pharmaceutical industries contribute to the growth of the drug delivery devices market in the Asia Pacific region. 

Some of the Prominent Companies leading the Asia-Pacific Drug Delivery Devices Market Profiled in the Report are Bend Research, Endocyte, Microchips Inc., Pearl Therapeutics Inc., Presage Bioscience, UCB Group, Genentech Inc., Polymer Factory, Alkermes Inc., BIND Biosciences Inc., and QLT Inc.

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample